Latest news and articles about pharmaceuticals from NEX English
The escalation of the war in Iran has led to disruptions in the Strait of Hormuz and the Gulf airspace, negatively impacting global drug supply chains. Although stocks are temporarily available, transportation costs and shipment delays have significantly increased.
The Governor of East Java, Khofifah Indar Parawansa, emphasized the importance of boosting local pharmaceutical production to reduce reliance on imports during the inauguration of a new drug factory in Pasuruan.
China is making remarkable strides in the fields of pharmaceuticals and biotechnology, with a notable increase in research conducted by Chinese scientists. This rapid development indicates China's growing ability to compete with the United States in this vital sector.
Indian pharmaceutical company Sun Pharma has announced its acquisition of American company Argenon in a fully cash deal valued at <strong>$11.75 billion</strong>. This acquisition aims to strengthen Sun Pharma's presence in the global market and expand its portfolio of drugs.
Fabros, a subsidiary of Indonesian Kimia Farma, reported a net profit of <strong>761.49 million rupiah</strong> in the first quarter of 2026, marking a significant increase of <strong>113%</strong> compared to the same period last year. This growth is attributed to increased sales and improved profit margins.
Regeneron Pharmaceuticals announced a historic agreement with U.S. President Donald Trump to reduce prices on certain medications in the United States. The deal also includes providing a new hearing loss treatment free of charge to eligible patients, reflecting ongoing efforts by the U.S. government to lower drug costs.
The Malaysian government has announced a new plan requiring pharmaceutical companies to report any potential supply shortages at least six months in advance, starting July 1. This initiative aims to bolster supply security amid global challenges.
Amazon has announced the availability of new weight loss pills developed by Lilly in its kiosks across the United States, with same-day delivery options. This move comes as the American market sees a growing demand for weight loss solutions.
The spokesperson for the Iranian Pharmacists Union reported that Israeli and American attacks have caused significant damage to 25 pharmaceutical facilities in Iran, raising concerns about the impact on the country's healthcare sector. This comes amid escalating tensions between Iran and the United States and its allies in the region.
On Thursday, U.S. President Donald Trump announced new tariffs on certain pharmaceuticals and a restructuring of tariffs on metals. This move reflects his ongoing trade policy aimed at protecting American industry.
The U.S. Environmental Protection Agency (EPA) announced plans to classify microplastics and pharmaceuticals as contaminants in drinking water, reflecting growing concerns about water quality and human health. This decision comes amid increasing global awareness of pollution risks.
German pharmaceutical giant Bayer has announced that it expects to generate most of its revenue from the American market following a strategic shift in its business model. This change comes as Europe faces challenges in providing affordable medications.
In a significant move, Tunisian President Kais Saied has authorized financial allocations for the Central Pharmacy, aiming to ensure a continuous supply of medications in the market. This decision comes as patients face a severe shortage of essential drugs.
Mercedes has announced its acquisition of Turns Pharmaceuticals for <strong>$6.7 billion</strong>, granting access to a promising treatment for <strong>blood cancer</strong>. This move comes as the company faces the expiration of a patent for one of its best-selling cancer drugs.